CSS
UTHR icon

Cubist Systematic Strategies’s United Therapeutics UTHR Stock Holding History

Cubist Systematic Strategies’s Portfolio UTHR Stock Details UTHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		$4.35M Buy
+10,371
New +$3.49M 0.02% 1046
2024
Q2 		– Sell
-886
Closed -$204K – 4069
2024
Q1 		$204K Sell
886
-53,727
-98% -$12.1M ﹤0.01% 3073
2023
Q4 		$12M Buy
54,613
+18,209
+50% +$4.2M 0.08% 356
2023
Q3 		$8.22M Buy
+36,404
New +$8.38M 0.06% 479
2023
Q2 		– Sell
-6,529
Closed -$1.45M – 4342
2023
Q1 		$1.46M Sell
6,529
-49,061
-88% -$12.1M 0.01% 1894
2022
Q4 		$15.5M Buy
55,590
+51,970
+1,436% +$13.1M 0.09% 264
2022
Q3 		$758K Sell
3,620
-38,162
-91% -$8.53M ﹤0.01% 2851
2022
Q2 		$9.85M Buy
41,782
+38,225
+1,075% +$7.77M 0.06% 457
2022
Q1 		$638K Sell
3,557
-9,346
-72% -$1.78M 0.01% 2380
2021
Q4 		$2.79M Sell
12,903
-31,833
-71% -$6.25M 0.03% 1086
2021
Q3 		$8.26M Buy
44,736
+44,091
+6,836% +$8.68M 0.1% 251
2021
Q2 		$116K Sell
645
-6,248
-91% -$1.19M ﹤0.01% 2700
2021
Q1 		$1.15M Buy
6,893
+2,323
+51% +$387K 0.01% 1445
2020
Q4 		$694K Sell
4,570
-44,455
-91% -$5.83M 0.01% 1593
2020
Q3 		$4.95M Buy
49,025
+32,414
+195% +$3.56M 0.07% 417
2020
Q2 		$2.01M Sell
16,611
-23,220
-58% -$2.61M 0.03% 791
2020
Q1 		$3.78M Sell
39,831
-50,729
-56% -$4.82M 0.1% 241
2019
Q4 		$7.98M Sell
90,560
-3,561
-4% -$313K 0.15% 149
2019
Q3 		$7.51M Buy
94,121
+34,250
+57% +$2.76M 0.15% 175
2019
Q2 		$4.67M Buy
59,871
+51,990
+660% +$4.86M 0.09% 326
2019
Q1 		$925K Buy
7,881
+6,875
+683% +$801K 0.03% 807
2018
Q4 		$110K Buy
+1,006
New +$117K 0.01% 1743
2018
Q3 		– Sell
-4,882
Closed -$552K – 2088
2018
Q2 		$552K Buy
+4,882
New +$537K 0.03% 746
2018
Q1 		– Sell
-2,574
Closed -$381K – 2088
2017
Q4 		$381K Sell
2,574
-2,980
-54% -$379K 0.02% 1087
2017
Q3 		$651K Buy
5,554
+70
+1% +$8.94K 0.04% 656
2017
Q2 		$711K Buy
5,484
+3,433
+167% +$428K 0.05% 579
2017
Q1 		$278K Buy
2,051
+385
+23% +$58.3K 0.02% 968
2016
Q4 		$239K Sell
1,666
-4,947
-75% -$632K 0.02% 1133
2016
Q3 		$781K Buy
+6,613
New +$795K 0.05% 515
2016
Q2 		– Sell
-34,605
Closed -$3.86M – 1895
2016
Q1 		$3.86M Buy
34,605
+28,498
+467% +$3.61M 0.22% 80
2015
Q4 		$956K Sell
6,107
-5,657
-48% -$823K 0.06% 490
2015
Q3 		$1.54M Sell
11,764
-12,333
-51% -$1.98M 0.08% 364
2015
Q2 		$4.19M Buy
24,097
+13,435
+126% +$2.42M 0.2% 90
2015
Q1 		$1.84M Buy
10,662
+4,050
+61% +$617K 0.09% 310
2014
Q4 		$856K Sell
6,612
-4,234
-39% -$546K 0.05% 579
2014
Q3 		$1.4M Sell
10,846
-16,779
-61% -$1.73M 0.09% 318
2014
Q2 		$2.44M Buy
+27,625
New +$2.66M 0.15% 177

Other funds holding UTHR

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
DGM
Darwin Global Management St. Helier, Jersey $3.77B AUM 307.72% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return

Cubist Systematic Strategies's UTHR Position: Q3 2025 in Review

Cubist Systematic Strategies opened a new position in United Therapeutics (UTHR) in Q3 2025: 10,371 shares worth $4.35M. The stake represents 0.02% of the portfolio and ranks #1046 among its holdings. This is a return to the name: Cubist Systematic Strategies previously reported a position in UTHR as recently as Q1 2024.

Cubist Systematic Strategies first reported a position in UTHR in Q2 2014 and has held it in 37 quarters since. The position peaked at $15.5M in Q4 2022. 707 funds tracked by Wall St. Rank hold UTHR as of Q3 2025.

  • Cubist Systematic Strategies held 10,371 shares of United Therapeutics worth $4.35M as of Q3 2025.
  • United Therapeutics was a new Cubist Systematic Strategies position in Q3 2025.
  • United Therapeutics made up 0.02% of Cubist Systematic Strategies's portfolio in Q3 2025, its #1046 holding.
  • Cubist Systematic Strategies first reported a position in United Therapeutics in Q2 2014 and has held it in 37 quarters since.
  • Cubist Systematic Strategies's United Therapeutics position peaked at $15.5M in Q4 2022.
  • 707 funds tracked by Wall St. Rank held United Therapeutics as of Q3 2025.

Based on Cubist Systematic Strategies's 13F filing for Q3 2025, filed 14 Nov 2025.